Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Constipation-predominant Irritable Bowel Syndrome

NCT01714843 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01714843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01714843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Constipation-predominant Irritable Bowel Syndrome
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
August 10, 2012
Completion date
December 7, 2013
Enrollment
559 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

constipation-predominant irritable bowel syndrome (ibs-c)